I will be on a great panel on risk-based monitoring and eSource methodologies at DIA June 16, and I want to highlight a few points from my presentation.
Site Engagement and Monitoring
Quintiles' global head of integrated site services Lindy Jones was a featured speaker at the recent Site Solutions Summit. Hosted by the Society for Clinical Research Sites (SCRS), the summit focuses on clinical research site performance and brings together executives from site, sponsor, CRO and supplier organizations.
It’s no secret that clinical trial complexity and drug development costs are at an all-time high. With more than 30 percent of trial budgets allocated to site monitoring costs—and more than half of that being spent on source document verification (SDV) activities¹—the idea of implementing a risk-based monitoring (RBM) program to rid ourselves of the traditional 100-percent-SDV approach has the life sciences industry buzzing.
The 9th annual Site Solutions Summit on Amelia Island Island brought together clinical research sites and industry leaders to discuss how we can help sites reach optimal performance. Medidata's Steve Young participated in the "Metrics, Metrics, Metrics: What's Important" crowdsolving panel discussion, along with peers from INC Research, Quintiles and MedPoint Digital.
Medidata's Richard Young goes over the fundamentals of the new approach to site monitoring that we refer to as risk-based monitoring. Tweet This: